A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.

Chantell Evans, PhD, an assistant professor of cell biology in the School of Medicine, has been selected to receive a 2022 Sloan Research Fellowship from the Alfred P. Sloan Foundation.

Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate.

Duke’s long leadership in vaccine research and the Duke Human Vaccine Institute’s (DHVI) dogged 25-year pursuit of answers to HIV put the university and health system in an excellent position to address the sudden, global challenge of the novel RNA coronavirus SARS-Cov-2 when it began to sweep around the world in 2020.  

Women’s reproductive health encompasses a continuum of a woman’s lifespan. Five Duke experts addressed a number of these topics on Feb. 2 as a part of Research Week 2022. 

The COVID-19 pandemic has exacerbated pre-existing health inequities and emphasized the need for community-engaged research to address those disparities, according to a panel of Duke and UNC-Chapel Hill experts. 

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally.

Duke University recently launched Duke Science and Technology (DST), a fundraising and faculty recruitment and retention effort aimed at elevating and sustaining excellence in the sciences. The effort is designed to accelerate the recruitment of new faculty and expand core research strengths in three main areas: resilience of the body and brain, computation, and materials science.

Elizabeth Hughes, a postdoc in Raphael Valdivia's lab, has been named a Damon Runyon Fellow

The emerging field of onco-fertility brings together oncology and reproductive endocrinology specialties to maximize the reproductive potential of cancer patients and survivors.